Senseonics Holdings, Inc. has entered into a Master Asset Purchase Agreement to acquire assets related to the Eversense® product from Ascensia Diabetes Care, worth approximately $1.1 million, effective January 1, 2026.
AI Assistant
SENSEONICS HOLDINGS INC
2026
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.